3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine

C108H109Br4N41O17S — CID 157368144

About 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine

3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine (PubChem CID 157368144) has the molecular formula C108H109Br4N41O17S and a molecular weight of 2605.01 g/mol. Its IUPAC name is 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine.

Molecular Properties

• Compound Name: 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine
• PubChem CID: 157368144
• Molecular Formula: C108H109Br4N41O17S
• Molecular Weight: 2605.01 g/mol
• Exact Mass: 2599.54
• IUPAC Name: 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine
• SMILES: CC(C)(C)OC(=O)Nc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.CC(C)(C)OC(=O)Nc1ncc(N2CCNCC2)nc1-c1nnc(-c2ccccc2)o1.CCS(=O)(=O)N1CCN(c2cnc(N)c(-c3nnc(-c4ccccc4)o3)n2)CC1.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.Nc1ncc(Br)nc1C(=O)NCC(=O)c1ccccc1.Nc1ncc(Br)nc1C(=O)O.Nc1ncc(N2CCNCC2)nc1-c1nnc(-c2ccccc2)o1
• InChI: InChI=1S/C21H25N7O3.C18H21N7O3S.C17H16BrN5O3.C16H17N7O.C13H11BrN4O2.C12H8BrN5O.C6H7N3O2.C5H4BrN3O2/c1-21(2,3)31-20(29)25-17-16(24-15(13-23-17)28-11-9-22-10-12-28)19-27-26-18(30-19)14-7-5-4-6-8-14;1-2-29(26,27)25-10-8-24(9-11-25)14-12-20-16(19)15(21-14)18-23-22-17(28-18)13-6-4-3-5-7-13;1-17(2,3)26-16(24)21-13-12(20-11(18)9-19-13)15-23-22-14(25-15)10-7-5-4-6-8-10;17-14-13(20-12(10-19-14)23-8-6-18-7-9-23)16-22-21-15(24-16)11-4-2-1-3-5-11;14-10-7-16-12(15)11(18-10)13(20)17-6-9(19)8-4-2-1-3-5-8;13-8-6-15-10(14)9(16-8)12-18-17-11(19-12)7-4-2-1-3-5-7;1-11-6(10)4-5(7)9-3-2-8-4;6-2-1-8-4(7)3(9-2)5(10)11/h4-8,13,22H,9-12H2,1-3H3,(H,23,25,29);3-7,12H,2,8-11H2,1H3,(H2,19,20);4-9H,1-3H3,(H,19,21,24);1-5,10,18H,6-9H2,(H2,17,19);1-5,7H,6H2,(H2,15,16)(H,17,20);1-6H,(H2,14,15);2-3H,1H3,(H2,7,9);1H,(H2,7,8)(H,10,11)
• InChIKey: BJKXDLUHISUXFA-UHFFFAOYSA-N
• XLogP: 14.02
• TPSA: 814.55 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 53
• Rotatable Bonds: 23
• Heavy Atoms: 171
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2605.01
LogP ≤ 5	14.02
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	53

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine?

The IUPAC name of 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine (CID 157368144) is 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine.

What is the SMILES notation for 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine?

The canonical SMILES for 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine is CC(C)(C)OC(=O)Nc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.CC(C)(C)OC(=O)Nc1ncc(N2CCNCC2)nc1-c1nnc(-c2ccccc2)o1.CCS(=O)(=O)N1CCN(c2cnc(N)c(-c3nnc(-c4ccccc4)o3)n2)CC1.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.Nc1ncc(Br)nc1C(=O)NCC(=O)c1ccccc1.Nc1ncc(Br)nc1C(=O)O.Nc1ncc(N2CCNCC2)nc1-c1nnc(-c2ccccc2)o1.

What is the InChIKey of 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine?

The InChIKey is BJKXDLUHISUXFA-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N7O3.C18H21N7O3S.C17H16BrN5O3.C16H17N7O.C13H11BrN4O2.C12H8BrN5O.C6H7N3O2.C5H4BrN3O2/c1-21(2,3)31-20(29)25-17-16(24-15(13-23-17)28-11-9-22-10-12-28)19-27-26-18(30-19)14-7-5-4-6-8-14;1-2-29(26,27)25-10-8-24(9-11-25)14-12-20-16(19)15(21-14)18-23-22-17(28-18)13-6-4-3-5-7-13;1-17(2,3)26-16(24)21-13-12(20-11(18)9-19-13)15-23-22-14(25-15)10-7-5-4-6-8-10;17-14-13(20-12(10-19-14)23-8-6-18-7-9-23)16-22-21-15(24-16)11-4-2-1-3-5-11;14-10-7-16-12(15)11(18-10)13(20)17-6-9(19)8-4-2-1-3-5-8;13-8-6-15-10(14)9(16-8)12-18-17-11(19-12)7-4-2-1-3-5-7;1-11-6(10)4-5(7)9-3-2-8-4;6-2-1-8-4(7)3(9-2)5(10)11/h4-8,13,22H,9-12H2,1-3H3,(H,23,25,29);3-7,12H,2,8-11H2,1H3,(H2,19,20);4-9H,1-3H3,(H,19,21,24);1-5,10,18H,6-9H2,(H2,17,19);1-5,7H,6H2,(H2,15,16)(H,17,20);1-6H,(H2,14,15);2-3H,1H3,(H2,7,9);1H,(H2,7,8)(H,10,11).

What are the key properties of 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine?

3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine has a molecular weight of 2605.01 g/mol, XLogP of 14.02, 23 rotatable bonds, 12 hydrogen bond donors, and 53 hydrogen bond acceptors.

Where does this data come from?

All data for 3-amino-6-bromo-N-phenacylpyrazine-2-carboxamide;3-amino-6-bromopyrazine-2-carboxylic acid;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]carbamate;tert-butyl N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-yl]carbamate;5-(4-ethylsulfonylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate;3-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-piperazin-1-ylpyrazin-2-amine is sourced from PubChem (CID 157368144), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).